A division of GE Healthcare, Amsersham Biosciences, was accused of Medicare fraud in 2006. A Michigan man acted as the whistleblower in the case when he informed the government about the company providing false information regarding the radiopharmaceutical agent, Myoview.
The whistleblower claimed that Amsersham Biosciences committed fraud when they relayed false information to the Medicare program between 2000 and 2003. The company was charged with diluting the agent as well as increasing the prices for the product.
The lawsuit has been settled and GE Healthcare has agreed to pay $30 million. The whistleblower who shed light on the fraud will receive $5 million for his part in the lawsuit.
If you have information regarding health care fraud and are interested in filing a Qui Tam lawsuit, please contact the health care fraud lawyers of Tycko & Zavareei, LLP by calling 202-973-0900 today.



